Global Evidence and Outcomes, Takeda, Lexington, MA, USA.
Evidence Synthesis, Modeling & Communication, Evidera, London, UK.
J Int Med Res. 2021 Jul;49(7):3000605211028026. doi: 10.1177/03000605211028026.
Neurodevelopmental impairment (NDI) is a major complication of extreme prematurity. This systematic review was conducted to summarize the worldwide long-term prevalence of NDI associated with extreme prematurity.
Embase and MEDLINE databases were searched for epidemiologic and observational/real-world studies, published in English between 2011 and 2016, reporting long-term prevalence of NDI (occurring from 1 year) among extremely preterm infants born at gestational age (GA) ≤28 weeks.
Of 2406 articles identified through searches, 69 met the protocol NDI definition (24 North America, 25 Europe, 20 Rest of World). Prevalence of any severity NDI in North America was 8%-59% at 18 months to 2 years, and 11%-37% at 2-5 years; prevalence of moderate NDI in Europe was 10%-13% at 18 months to 2 years, 3% at 2-5 years, and 9%-19% at ≥5 years; prevalence of any NDI in Rest of World was 15%-61% at 18 months to 2 years, and 42% at 2-5 years (no North America/Rest of World studies reported any NDI at ≥5 years). A trend toward higher prevalence of NDI with lower GA at birth was observed.
Extreme prematurity has a significant long-term worldwide impact on neurodevelopmental outcomes.
神经发育障碍(NDI)是极早产儿的主要并发症。本系统评价旨在总结全球范围内与极早产儿相关的 NDI 的长期患病率。
检索 Embase 和 MEDLINE 数据库,以获取 2011 年至 2016 年间发表的、关于极早产儿(胎龄(GA)≤28 周)出生后 1 年以上的 NDI 长期患病率的流行病学和观察性/真实世界研究的英文文章。
通过检索共确定了 2406 篇文章,其中 69 篇符合方案中 NDI 定义(北美 24 篇,欧洲 25 篇,世界其他地区 20 篇)。北美极早产儿在 18 个月至 2 岁时,任何严重程度的 NDI 患病率为 8%-59%,2-5 岁时为 11%-37%;欧洲极早产儿在 18 个月至 2 岁时,中度 NDI 的患病率为 10%-13%,2-5 岁时为 3%,≥5 岁时为 9%-19%;世界其他地区极早产儿在 18 个月至 2 岁时,任何程度的 NDI 患病率为 15%-61%,2-5 岁时为 42%(北美/世界其他地区没有研究报告≥5 岁时的任何 NDI)。观察到随着出生时 GA 的降低,NDI 的患病率呈上升趋势。
极早产对神经发育结局具有显著的全球性长期影响。